Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas

Journal of the American Academy of Dermatology

Volumn 46, Issue 1, 2002, Pages 95-106

  Vonderheid, Eric C ^a   Bernengo, Maria Grazia ^b   Burg, Günter ^c   Duvic, Madeleine ^d   Heald, Peter ^e   Laroche, Liliane ^f   Olsen, Elise ^g   Pittelkow, Mark ^h   Russell Jones, Robin ⁱ   Takigawa, Masahiro ^j   Willemze, Rein ^k  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e YALE UNIVERSITY   (United States)

^f UNIVERSITÉ PARIS 13   (France)

^g DUKE UNIVERSITY   (United States)

^h MAYO CLINIC   (United States)

ⁱ ST THOMAS HOSPITAL   (United Kingdom)

^j HAMAMATSU UNIVERSITY   (Japan)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CHROMOSOME ABERRATION; DISEASE CLASSIFICATION; ERYTHRODERMA; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LYMPHOCYTE CLONE; LYMPHOCYTE COUNT; MYCOSIS FUNGOIDES; NOMENCLATURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SEZARY CELL; SEZARY SYNDROME; SKIN LYMPHOMA; SOUTHERN BLOTTING; T CELL LYMPHOMA;

EID: 18244392691     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.118538     Document Type: Article

References (94)

1. Mycosis fungoides and Sézary syndrome
2. Mycosis fungoides: Relationship to malignant and cutaneous reticulosis and the Sézary syndrome
3. Cutaneous T-cell lymphoma
4. Cutaneous T-cell lymphomas: The Sézary syndrome, mycosis fungoides, and related disorders
5. Cutaneous T-cell lymphomas: Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute workshop
6. On the erythroderma of mycosis fungoides
7. Analysis of clinical, histopathologic and immunopathologic parameters in erythrodermic variants of cutaneous T-cell lymphoma with implications for staging
8. Erythrodermie avec présence de cellules monstrueuses dans le derme et le sang circulant
9. Sézary's syndrome
10. Sézary syndrome: A malignant reticulemic erythroderma
11. The ultrastructure of an abnormal cell in Sézary's syndrome
12. Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of the small-cell variant
13. Quantitative measurements of blood lymphocytes from patients with chronic lymphocytic leukemia and the Sézary syndrome
14. Lymphoblastoma (mycosis fungoides) and hemorrhagic sarcoma of Kaposi in the same person
15. The Sézary cell: Cytologic, cytochemical, and immunologic studies
16. Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma
17. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: Definition of three distinctive prognostic groups
18. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome
19. Ultrastructure of abnormal cells in Sézary syndrome, mycosis fungoides, and parapsoriasis en plaque
20. Ultrastructural appearance of cutaneous T cell lymphomas in skin, lymph nodes, and peripheral blood
21. Ultrastructural morphometry in the diagnosis of mycosis fungoides and Sézary's syndrome
22. Cerebriform (Sézary like) mononuclear cells in healthy individuals: A morphologically distinct population of T cells
23. Candidate counterparts of Sézary cells and adult T-cell lymphoma-leukemia cells in normal peripheral blood: An ultrastructural study with the immunogold method and monoclonal antibodies
24. Induction of nuclear contour irregularity during T-cell activation via the T-cell receptor/CD3 complex and CD2 antigens in the presence of phorbol esters
25. Diagnostic criteria in Sézary's syndrome: A multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma
26. Diagnostic and prognostic significance of Sézary cells in peripheral blood smears from patients with cutaneous T cell lymphoma
27. T cell imbalance in nonleukemic and leukemic cutaneous lymphoma defined by monoclonal antibodies
28. Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells
29. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac
30. Sézary syndrome: Phenotypic and functional characterization of the neoplastic cells
31. Differential expression of CD24-related epitopes in mycosis fungoides/Sézary syndrome: A potential marker for circulating Sézary cells
32. CD7 expression on the circulating lymphocytes in patients with Sézary syndrome
33. Mycosis fungoides/Sézary's syndrome progressing to immunoblastic sarcoma: A T-cell lymphoproliferation with both helper and suppressor phenotype
34. Expression of TIA-1 and TIA-2 in T cell malignancies and T cell lymphocytosis
35. Prognostic factors in Sézary syndrome: A multivariate analysis of clinical, haematological and immunological features
36. Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression
37. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses
38. Immunophenotypic identification of Sézary cells in peripheral blood
39. Differential expression of CD3 and CD7 in T-cell malignancies: A quantitative study by flow cytometry
40. Expression of Vβ gene segments by Sézary cells
41. Failure of anti-T-cell receptor Vβ antibodies to consistently identify a malignant T-cell clone in Sézary syndrome
42. Detection of circulating neoplastic T cells in patients with Sézary syndrome and erythrodermic mycosis fungoides by three-color immunofluorescence flow cytometry
43. Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: Cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease
44. +CD26subset in the identification of circulating Sézary cells
45. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
46. Molecular biologic techniques for the diagnosis of CTCL
47. Detection of monoclonal lymphoid cell populations by polymerase chain reaction technology
48. T-cell receptor gene analysis in cutaneous T-cell lymphomas
49. Detection of clonal T-cell receptor γ gene rearrangements in early mycosis fungoides/Sézary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE)
50. Cutaneous T-cell infiltrates: Analysis of T-cell receptor γ gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis
51. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma
52. Demonstration of frequent occurrence of clonal T cells in the peripheral blood but not the skin of patients with small plaque parapsoriasis
53. +/CD7T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas
54. Detection of a peripheral blood T-cell clone is an independent prognostic marker in mycosis fungoides
55. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas
56. Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms
57. Genotypic analysis of cutaneous T-cell lymphomas
58. Dual genotype in cutaneous T cell lymphoma: Immunoglobulin gene rearrangement in clonal T cell malignancy
59. Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sézary syndrome
60. Diagnostic value of T-cell receptor beta gene rearrangement analysis on peripheral blood lymphocytes of patients with erythroderma
61. T-cell receptor gene rearrangement analysis: Cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders
62. Analysis of β, γ, and δ T-cell receptor genes in mycosis fungoides and Sézary syndrome
63. The clonal nature of circulating Sézary cells
64. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor γ gene rearrangement analysis and immunophenotyping
65. T-cell receptor gene analysis in the diagnosis of Sézary syndrome
66. Sézary syndrome: A clinico-pathologic study of 39 cases
67. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: A comparison with benign forms of erythroderma
68. Cutaneous histopathology of Sézary syndrome: A study of 41 cases with a proven circulating T-cell clone
69. Immunologic differentiation of the Sézary syndrome due to cutaneous T-cell lymphoma and chronic actinic dermatitis
70. The diagnostic value of morphometry on blood lymphocytes in erythrodermic actinic reticuloid
71. Pseudolymphoma with mycosis fungoides manifestations, hyporesponsiveness to diphenylhydantoin, and lymphocyte dysregulation
72. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome
73. Lymph node histopathology in Sézary syndrome
74. A histologic study of lymph nodes from patients with the Sézary syndrome
75. A 10-year experience with topical mechlorethamine for mycosis fungoides: Comparison with patients treated by total-skin electron beam radiation therapy
76. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome
77. Circulating Sézary cells in hospitalized dermatology patients
78. The absence of Sézary cells in the peripheral blood of patients with generalized dermatoses
79. Sézary cell count in exfoliative dermatitis
80. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome
81. Growth, interleukin-2 production, and responsiveness to IL-2 in T4-positive T lymphocyte populations from malignant cutaneous T cell lymphoma (Sézary's syndrome): The effect of cyclosporine A
82. Application of a multiprobe RNase protection assay and junctional sequences to define Vβ gene diversity in Sézary syndrome
83. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma
84. Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma
85. Erythroderma with atypical lymphocytes (Sézary syndrome)
86. Clinical studies of T-cell erythroderma in the Sézary syndrome
87. Absolute number of circulating Sézary cells
88. Pre-Sézary syndrome
89. Pre-Sézary erythroderma evolving to Sézary syndrome
90. +CD7T lymphocyte subsets in Sézary syndrome
91. Cytogenetic studies and clinical implications in patients with Sézary syndrome
92. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL)
93. Clonal characteristics of cutaneous T cell lymphomas: Cytogenetic evidence from blood, lymph nodes, and skin
94. Chromosome studies in 17 patients with the Sézary syndrome